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1. Introduction
Urinary tract infections (UTIs) are significant problem in infants and children and may be
associated with renal scarring, which can cause serious long-term complications particularly
hypertension and renal failure. The common characteristic of all UTIs is a significant growth
of bacteria in the urinary tract. Uropathogenic Escherichia coli (E. coli) is the primary causa‐
tive agent of UTIs.
Symptomatic UTIs can be classified into infections limited to the lower urinary tract and in‐
fections of the upper urinary tract. Marked individual differences in susceptibility to UTIs
have been known for decades. Through different molecular interactions bacteria may trigger
epithelial cell responses, cause cell detachment and invade or kill cells by apoptosis. The in‐
dividual inflammatory response determines severity of acute pyelonephritis (APN) as well
as differences in response to UTI among individuals. It is suggested that APN occurs more
readily in high responders. Level of individual inflammatory response could be a key of
enigma why some patients with APN develop renal scarring and progressive kidney dam‐
age whereas others do not.
Identification of new markers underlying APN and affecting its treatment is essential for de‐
signing interventions that would minimize tissue damage. Research of individual genetic
background of inflammatory response suggests the significance of proinflammatory cyto‐
kine genes and polymorphisms of these genes. Such polymorphisms can occur either in reg‐
ulatory or in coding regions of genes. They may affect the level of inflammation by
enhancing transcription of certain cytokines’ genes and thus increasing production of these
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cytokines. Changes in genes’ expression as well as presence of certain alleles associated with
disease phenotype support the hypothesis that genetic factors could modify susceptibility to
acute pyelonephritis and post-infectious renal damage.
Several mechanical forces including urine flow and voiding, mucus shedding, and epithelial
cell sloughing are important in minimizing UTI incidence. Bacterial adherence to the epithe‐
lium triggers defense responses. One of these is innate immunity response, which is impor‐
tant for uropathogenic E. coli recognition and immunomobilization. The innate immunity
response is mediated by toll-like receptors (TLR4, TLR5, TLR11), adhesion molecules (E-se‐
lectin, ICAM-1, PECAM-1) and secreted factors such as cytokines (TNF-alpha, IL-1beta, IL-6,
G-CSF, IL-17) and chemokines (CXCL1, CXCL2, CXCL3, CXCL8, CCL4). These molecules
have been detected in mammalian bladder upon infection. Therefore, polymorphisms in
genes coding for these molecules have been recognized as genetic susceptibility factors for
UTIs. Neutrophils are the most abundant early responders to infection, while the anti‐
gen(Ag)-presenting macrophages, dendritic cells and innate-like lymphocytes (such as gam‐
ma delta T cells) have been implicated in the UTI host defense.
The cytokine response is  essential  for antibacterial  defense of the urinary tract.  Interleu‐
kin-8  (IL-8)  is  a  potent  chemoattractant  responsible  for  neutrophil  infiltration  into  the
urinary tract.  It  was reported that  neutrophils  of  children with recurrent  pyelonephritis
had lower expression of  IL-8 receptor (CXCR1) than neutrophils  of  healthy controls.  In‐
terleukin-6 (IL-6)  is  one of  the pro-inflammatory cytokines,  which stimulates production
of  all  acute-phase  proteins  thus  contributing  to  acute-phase  response  and  systemic  in‐
flammation. High serum or urine levels of IL-6 have been found in children with UTIs,
particularly in children with APN compared to those with lower UTI.  It  was also indi‐
cated  that  urine  and  serum  levels  of  cytokines  could  be  observed  as  markers  of  renal
damage  as  well  as  tools  for  monitoring  the  development  and  outcome  of  APN.  Urine
analysis  has been extensively used by clinicians to diagnose various renal  diseases.  Ad‐
vances in technology of molecular biology enable analyses of genes’ expression levels in
urine  sediment.  These  expression  studies  have  a  potential  to  improve  the  diagnosis  of
APN by detecting urinary gene expression profiles,  which are  specific  for  patients  with
APN.
Besides susceptibility to UTIs, of great therapeutic importance is susceptibility to post-infec‐
tious renal damage in APN patients. This kidney damage susceptibility has the genetic com‐
ponent. Among the candidate genes are those coding for molecules like growth factors
(TGF-β1, VEGF), which play important roles in processes characteristic for the tissue dam‐
age and scarring such as cell proliferation and accumulation of extracellular matrix. Angio‐
tensin II, main effector of the renin-angiotensin system, is also considered a growth factor
involved in all phenomena of renal tissue damaging and scar formation.
Here we will review the roles of candidate genes’ polymorphisms and expression in sus‐
ceptibility to APN and post-infectious renal scarring, in order to summarize the existing re‐
sults and point out to further possible directions for research in this field.
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2. Acute Pyelonephritis (APN) in children and genetic susceptibility to APN
Urinary tract infections (UTIs) are common among children of all ages including infants.
UTI is defined as a penetration of microorganisms, mainly E. coli, into the tissue of urina‐
ry  tract,  which is  marked by significant  bacteriuria  (>105  bacteria  per  1ml  of  urine)  [1].
UTIs  are  classified  into  three  categories:  upper  UTI-  acute  pyelonephritis,  lower  UTI-
acute cystitis and asymptomatic bacteriuria (ABU). The upper UTI, or acute pyelonephri‐
tis  (APN),  represents  bacterial  infection of  renal  parenchyma,  which may cause  various
inflammatory lesions.  Post-infectious renal  scarring is  the most  serious complication fol‐
lowing APN in children, with an estimated incidence of 10-65% [1-2]. Vesico-ureteral re‐
flux (VUR) may also play an important role in renal damage [3]. VUR is suggested to be a
weak predictor of permanent renal damage in children hospitalized with UTI [4] but it is
also known that the grade of VUR positively correlates with likelihood of renal scarring
[5]. Extensive renal scarring leads to renal insufficiency and hypertension [6-7]. Early diag‐
nosis of APN and follow up to identify renal scarring after the first  APN are thus very
important. The primary distinction of APN is based on clinical manifestations and indirect
laboratory testing of inflammatory markers such as C-reactive protein (CRP) serum levels,
peripheral white blood cells’ (WBC) count etc. However, these tests are unreliable in acute
phase of pyelonephritis. The  99mTc-dimercaptosuccinic acid (DMSA) scintigraphy is a gold‐
en standard method for detection of acute renal inflammatory lesions specific for diagno‐
sis of APN as well as for the follow-up detection of renal cortical scars [8-9]. Detection of
permanent renal parenchymal defects following APN is ultimate for long-term prognosis
of kidney function. The incidence of renal defects correlates inversely with the time inter‐
val between pyelonephritis and the scintigraphic study and stabilizes 4-6 months follow‐
ing  acute  disease.  DMSA  scintigraphy  is  based  on  binding  of  99mTc-DMSA  to  renal
parenchyma cells  and therefore  provides means of  distinguishing APN from lower UTI
and evaluating persistent  DMSA uptake defects  after  the initial  infection in children [8-
10].  Given that  DMSA exposes the patients  to  radiation,  this  procedure is  not  regularly
used to diagnose APN.
2.1. Bacterial virulence and uroepithelial contact
Uropathogenic Escherichia coli is the most common causative agent (80%) of uncomplicated
UTIs although other enteric organisms have been identified as well [11]. After colonization
of the urethra and ascent to the bladder, bacteria bind to glycosphingolipid and glycopro‐
tein receptors on the urinary tract epithelium and penetrate into tissue of urinary tract [12].
They express a number of virulence determinants that contribute to successful colonization
of the urinary tract [13]. Many pathogenic microorganisms use host cell surface oligosac‐
charides including glycosphingolipids (GSLs) as receptors to attach to uroepithelial cells.
The attachment of E. coli is mediated trough expression of flagellin and ascending of E. coli
to the upper urinary tract and dissemination of bacteria within the host are enabled through
a flagellum-mediated motility [14-16]. These actions, along with the lipid A moiety of lipo‐
polysaccharide (endotoxin), have been shown to enhance activation of the host inflammato‐
ry response. Cytokines mediate this response [7,17-19]. Neutrophils are the first cells that
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migrate to the uroepithelium in the event of UTI and they are crucial in control of infection
at early time points [20].
2.2. Renal scarring following APN
Bacterial infection of renal parenchyma during APN represents the major cause of acquired
renal damage in children. The inflammatory changes associated with acute pyelonephritis
are reversible but in some cases they result in renal defects. The percentage of children with
renal scarring detected six months after the first APN is similar in the recent studies [21-23]
and is in agreement with the results of European meta-analysis study of post-pyelonephritic
renal scarring incidence [24]. Post-infectious renal scarring, as the most serious complication
following APN, appears in 10-65% of children [8,25]. This renal damage can lead to hyper‐
tension and chronic renal failure [26-28].
The actual etiology of renal scarring remains controversial. The risk factors supposed to be
associated with renal scars are: presence of vesico-ureteral reflux (VUR), delay in adequate
antibiotic treatment, presence of recurrent UTI, bacterial virulence, host defense factors, host
inflammatory and immunologic reactions and genetic susceptibility.
2.3. Vesico-Ureteral Reflux (VUR) as a risk factor for renal scarring
VUR is classically considered a risk factor for development of renal scars. The theory that
reflux might play an important role in renal damage was proposed by Hodson and Edvards
in 1960 [29]. Ransley and Risdon showed that scarring occurred only when urinary infection
was present in association with VUR and intrarenal reflux [30]. Later it was suggested that
VUR was a weak predictor of permanent renal damage in children hospitalized with UTI
[31]. However, development of scars occurred even in absence of VUR, so there has been a
debate for many years over the role of VUR in children who developed renal scars following
UTI [31-35]. There is also a debate whether the grade of VUR positively correlates with like‐
lihood of renal scarring or not [36] and whether the age represents a risk factor for scars’
formation [37]. Gleeson and Gordon reported that there was a significant correlation be‐
tween detection of a scarred kidney on DMSA scan and presence of VUR in children who
were less than one year old [37]. In children aged over one year there was a poor correlation
with renal scarring, so they suggested that the young growing kidney might be more vul‐
nerable to insults. However, others [25,38-39] did not confirm that younger children were at
greater risk for development of renal sequelae following pyelonephritis. Moreover, in some
studies [40] children aged over one year had a higher frequency of renal scarring in compar‐
ison to infants.
2.4. Host inflammatory response and kidney damage following APN
Roberts et al. have suggested that the acute inflammatory response causing the eradication
of bacteria could be responsible for the early pyelonephritic damage of renal tissue and sub‐
sequent renal scarring [41]. Neutrophils migrate between tissue compartments and exert
their effector functions at different sites. They circulate in blood and interact with the endo‐
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thelial lining that they cross to reach peripheral tissues. There is increasing evidence that the
fate of neutrophils outside the vascular system is governed by specialized molecular interac‐
tions distinct from those in blood vessels [3] but these aspects have received less attention
and are not well understood. Mucosal pathogens trigger a rapid neutrophil response [4-5],
given that neutrophils are crucial effectors of the host defense [6-7]. The mucosal neutrophil
response initiates when bacteria stimulate the epithelial cells to secrete chemokines [5,42]
and to increase their chemokine receptors’ expression. Neutrophils respond to so-formed
chemotactic gradient, leave the bloodstream, travel through the submucosa and reach the
basal side of the epithelial barrier, which they cross into the lumen [3,42]. Attention has been
focused on molecular interactions of neutrophils with endothelial cells during the extravasa‐
tion process [1-2], because this is the key to subsequent pathology and tissue destruction.
2.5. Genetic susceptibility to APN and renal scarring following APN
The interindividual differences in frequency and severity of UTIs exist and they are con‐
sistent with a genetic predisposition among disease-prone individuals.  Structural  defects
such as congenital  anomalies of  kidney and urinary tract  as well  as social  and environ‐
mental  factors  influence  disease  susceptibility  [1-2].  There  have  been  many  attempts  to
identify the host factors that predispose to UTIs, especially to acute pyelonephritis (APN).
Recurrent  APN occurs  within  a  small  group of  highly  susceptible  individuals,  some of
whom  develop  progressive  renal  scarring  and  therefore  may  need  dialysis  or  kidney
transplantation [2-4].
In an attempt to characterize the critical mechanisms and candidate genes for APN suscepti‐
bility, the “knockout” mice were investigated. It has been shown that the innate immunity
response genes strongly influence susceptibility to UTIs, particularly APN [5-7].
Large interindividual differences both in frequency and severity of UTIs are consistent with
genetic predisposition among disease-prone individuals although inherited defects in mech‐
anisms of defense against UTIs have not been identified. Since the experimental studies sug‐
gested that susceptibility to clinical APN was genetically controlled and that the disease
severity might vary with the expression levels of specific host response molecules, the next
step was to investigate the susceptibility candidate genes in human population.
2.5.1. Cytokines
Phagocytosis of  microorganisms and their  intracellular degradation by the tissue macro‐
phages represent stimuli  for  synthesis  of  proinflammatory cytokines,  interleukin-1 (IL-1)
and tumor necrosis  factor-alpha (TNF-α)  [43].  IL-1  and TNF-α induce expression of  the
adhesion molecules on the surface of endothelial cells,  which bind the circulating leuko‐
cytes and allow their  recruitment into the tissue.  IL-1 and TNF-α also stimulate cells  of
the infected tissue to produce other mediators of inflammation such as cytokine interleu‐
kin-6 (IL-6) and chemokines, which regulate leukocytes’ functions as well as their transen‐
dothelial  migration  into  the  inflammatory  tissue  [43].  Chemokines,  particularly
interleukin-8 (IL-8), are released from stimulated endothelial cells and macrophages. They
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act  as  chemoattractants  stimulating  the  chemotaxis  of  neutrophils  and neutrophil  adhe‐
sion to stimulated endothelium [43,44].
Elevated serum levels of the proinflammatory cytokines- TNF-α, IL-1 and IL-6, have been
measured in children with UTIs, with a significantly greater increase in children with APN
than in those with lower UTI [10].
2.5.1.1. TNF-α
A single nucleotide polymorphism (SNP) -308 A/G in the promoter sequence of TNF-α gene
is located at the binding site of the transcription factor activating protein-2 [45]. It has been
suggested that TNF -308 A allele is related to a higher production of TNF-α [46]. No differ‐
ences have been demonstrated in TNF-α -308 A/G genotype frequencies between infants
with UTI (with and without renal scarring) and controls [47].
2.5.1.2. IL-6
Interleukin-6 (IL-6) is one of the pro-inflammatory cytokines, which stimulates production
of all acute-phase proteins thus contributing to acute-phase response and systemic inflam‐
mation [10]. IL-6 is synthesized by several types of cells, in response to various antigens
such as bacterial pathogens [48-49]. There are studies suggesting that IL-6 could be synthe‐
sized by uroepithelial or renal tubular cells [49-50]. High serum or urine levels of IL-6 have
been detected in children with UTIs, particularly in those with APN in comparison to those
with lower UTI [51-52]. It was indicated that urine and serum levels of this cytokine could
be observed as markers of renal damage as well as tools for monitoring the development
and outcome of APN [22,51-52].
Regulation of IL-6 expression is mainly accomplished at transcription level. A SNP -174 G/C,
in the promoter region of IL-6 gene, is located 11 bp upstream from cis-regulatory element
(CRE) and reported to influence the level of IL-6 expression in healthy individuals [53].
Moreover, -174 G/C polymorphism was found to be associated with circulating IL-6 levels
and course of certain inflammatory diseases [54-55]. This polymorphism was investigated in
association with APN and renal scarring in our study [21]. The genotype distributions and
allele frequencies were not significantly different between the two investigated patients’
groups, with APN and lower UTI. We concluded that IL-6 -174 G/C polymorphism was not
a susceptibility factor for APN. This polymorphism was neither recognized as a risk factor
for renal scarring in patients with the first APN [21]. Still, we detected a significant increase
in white blood cells’ count in APN children with CC genotype compared to those with wild
type, GG, genotype.
2.5.1.3. IL-8 and CXCR1
The IL-8 receptor, CXCR1, was identified a candidate gene for acute pyelonephritis when
mIL-8Rh mutant mice developed APN with severe tissue damage [6-7]. After sequencing
that covered the entire CXCR1 gene two genetic variants, +217 C/G and +2608 G/C, were
found to be susceptibility factors for APN in both children and adults [56]. Infants and chil‐
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dren included in this study have been followed from their first episode of APN and adults
had a history of APN in childhood. Kidney status was defined by DMSA scan. The UTI-as‐
sociated CXCR1 variant, +217 C/G, has been shown to reduce RUNX1 binding to the puta‐
tive intronic binding site. Furthermore, transfection experiments showed that transcription
level of the mutant allele was lower, suggesting that +217 C/G polymorphism could reduce
CXCR1 transcription [56].
The other study investigated polymorphisms of IL-8 gene, -251 A/T and +2767 A/G, and a
polymorphism +2608 G/C of IL-8 receptor gene (CXCR1) in children with the first episode of
upper UTI and APN documented by DMSA [18]. There were no statistically significant dif‐
ferences in genotype and allele frequencies of the IL-8 and CXCR1 polymorphisms between
the UTI population and controls [18]. After comparison of genotype frequencies between
DMSA positive children (with definite APN) and DMSA negative children, there were no
significant differences between these two groups. Still, IL-8 -251 TT genotype was signifi‐
cantly more frequent in DMSA negative children suggesting that a carriage of A allele repre‐
sents susceptibility factor for APN. By exclusion of patients with VUR, the genotype
frequencies between DMSA positive and DMSA negative children were significantly differ‐
ent for IL-8 gene polymorphisms, -251 A/T and +2767 A/G. Again, -251 TT homozygotes
were more frequent in DMSA negative children. These results, overall, suggest that IL-8 -251
A allele is significantly associated with presence of DMSA documented pyelonephritis [18].
Experimental data also showed that -251 A allele was associated with increase in IL-8 pro‐
duction in lipopolysaccharide stimulated whole blood [42]. The CXCR1 gene polymorphism
+2608 G/C was not associated with APN [18].
2.5.1.4. MCP-1/CCL2 and RANTES/CCL5
Polymorphisms of genes coding for MCP-1 (monocyte chemotactic protein-1)/CCL2 and
RANTES (Regulated upon Activation, Normal T-cell Expressed, and Secreted)/CCL5 and
their receptors, CCR2 and CCR5 respectively, have been associated with the upper UTI. On‐
ly RANTES -403 G allele was significantly associated with risk for UTI, irrespectively of
VUR [57].
2.5.2. Adhesion molecules
Initial steps of the inflammatory response are mediated by adhesion of inflammatory cells
(leukocytes) to vascular endothelial cells [58-59]. Inflammatory cells then exit the circulation
and infiltrate the surrounding tissue. This process is mediated by E-selectin, intercellular ad‐
hesion molecule-1 (ICAM-1) and platelet endothelial cell adhesion molecule-1 (PECAM-1)
through the sequential steps of rolling, strong adhesion and diapedesis, respectively [59-60].
Data from ICAM-1 knockout animals showed that these animals had elevated neutrophil
and lymphocyte counts and decreased neutrophil influx to the site of infection [61].
In the group of children with a proven history of UTI, E-selectin, ICAM-1, PECAM-1 and
CD11b gene polymorphisms were investigated. There were no significant differences in al‐
lele frequencies between patients and controls for any of the investigated polymorphisms
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[62]. Still, A allele of ICAM-1 exon 4 (G/A) polymorphism had significantly lower frequency
in patients who developed renal scars following UTI compared with the patients without
scars. This suggested that the A allele might be a protective factor for renal scarring follow‐
ing UTI. It is possible that protective effect of the A allele on development of renal scars fol‐
lowing UTI may be a result of decreased binding of neutrophils and other inflammatory
cells to ICAM-1, resulting in reduced leukocyte infiltration and reduced tissue damage [62].
2.5.3. Toll-Like Receptors (TLRs)
Toll-like receptors’ (TLRs) genes are among the most commonly studied in association with
UTIs. Toll-like receptors are critical sensors of microbial attack and effectors of the TLR-de‐
pendent innate defense, which enables host to eliminate pathogens [63-65]. TLRs are located
on the cell surface or within organelles, like phagosomes, and are involved in detection of
microbial ligands such as flagellin (TLR5), lipopolysaccharide (TLR4) and bacterial lipopep‐
tides (TLR1/2/6) [66].
Given that TLRs play a crucial role in the innate immune defense, their structures and func‐
tions are tightly regulated [67]. Numerous attempts have been made to identify TLRs struc‐
tural genes’ variations, which might be related to diseases. Structural gene polymorphisms
are relatively rare [68] and their contributions to human diseases still remain unclear.
Recently, TLR4 gene promoter region has been shown considerably more variable than pre‐
viously known [69]. It’s been suggested that few genotype patterns might reflect selection
for low-responder variants in the primary asymptomatic bacteriuria group, which might
protect against severe UTI [69]. Previously, low TLR4 expression had mostly been attributed
to tolerance and not to genetic variation affecting TLR4 expression. Recently, the first study
proposing impact of TLR4 promoter genetic variants on TLR4 expression has been publish‐
ed [69]. The authors have shown that single and multiple SNPs mostly suppressed TLR4
promoter activity in vitro, especially in response to E. coli infection. They have also observed
that TLR4 promoter sequence variations could influence clinical presentation of UTI.
Hawn et al. [70] suggested that TLR4 Asp299Gly polymorphism was associated with protec‐
tion from recurrent UTI, but not pyelonephritis. Furthermore, they showed that TLR5 +1174
C/T polymorphism was associated with an increased risk of recurrent UTI but not pyelo‐
nephritis, while a polymorphism in TLR1, +1805 G/T, was associated with protection from
pyelonephritis in women [70]. The study that included children with recurrent UTI did not
reveal a significant difference in Asp299Gly genotypes of TLR4 between children with UTI
and control group [71].
Another study showed a relationship between the carrier status of HSPA1B (heat shock 70
kDa protein 1B) +1267 G and TLR4 +896 G alleles and development of recurrent UTI in
childhood, independently on other urinary tract abnormalities [72]. Study in adults revealed
that TLR4 +896 G allele had higher prevalence in UTI patients than in controls, and that
TLR4 expression in monocytes was significantly lower in chronic UTI patients than in APN
patients or healthy controls [73].
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2.5.4. Vascular Endothelial Growth Factor (VEGF) and Transforming Growth Factor-beta1
(TGF-β1)
Vascular endothelial growth factor (VEGF) is a potent mitogen that enhances angiogene‐
sis, microvascular permeability and proliferation of vascular endothelial cells [74]. Expres‐
sion of VEGF has been detected in glomerular podocytes, epithelial cells of distal tubules
and collecting ducts of kidney. Neovascularization in scarred kidney tissue and significant
increase  of  urine  VEGF levels  associated  with  increased severity  of  renal  scarring  have
been reported [75-76].  Transforming growth factor-beta1  (TGF-β1)  appears  to  be  one  of
the key factors in process of tissue repair. It is involved in regulation of cell proliferation,
differentiation,  extracellular  matrix  production  and  immune  response  [77].  Studies  sug‐
gested that TGF-β1 could be involved in pathogenesis of congenital obstructive uropathies
and renal scarring [78].
Several polymorphisms in VEGF and TGF-β1 genes have been linked to overproduction of
these proteins as well as predisposition to progressive renal disease [79-81]. The VEGF -460
T/C polymorphism and TGF-β1 polymorphisms, -800 G/A and -509 C/T, have been associat‐
ed with UTI and VUR in children [82]. VEGF -460 CC genotype was significantly more fre‐
quent in children with UTI and VUR than in controls [82]. Presence of VEGF -460 C allele
increased basal VEGF promoter activity by 71% compared to the wild-type sequence [83].
Both UTI and VUR groups showed a significant increase in frequencies of TGF-β1 -800 GG
and -509 CC genotypes in comparison to controls [82]. Cotton et al. [81] observed a correla‐
tion between -800 GA genotype and low TGF-β1 production in vitro suggesting a protective
role against renal scarring. However, there was no correlation between TGF-β1 -509 geno‐
types and protein production [81].
In the study of Yim et al. [82], the UTI group was subdivided into two subgroups according
to presence of renal scars. Significantly increased frequency of TGF-β1 +869 CC genotype
was found in the subgroup of patients positive for renal scarring [82]. A study of nephrop‐
athy resulted in an association of the +869 CC genotype with heavy proteinuria and a higher
score of mesangial cell proliferation [84].
2.5.5. Angiotensin I-Converting Enzyme (ACE)
Angiotensin II (Ang II), a powerful effector peptide of the renin-angiotensin system (RAS),
is now considered a growth factor that plays active roles in all phenomena characteristic for
renal tissue damage such as: proliferation of cells, accumulation of extracellular matrix and
mononuclear cells’ recruitment [19,85-87]. Since local kidney and interstitial fluid levels of
Ang II are higher than the circulating [87], a blockade of Ang II actions may provide protec‐
tion against functional and structural kidney deterioration.
Angiotensin I-converting enzyme (ACE), representing a target for ACE inhibitors (ACEI), is
the key enzyme of RAS system. An insertion/deletion (I/D) polymorphism resulting from
the presence/absence of a 287 bp Alu sequence has been identified in intron 16 of ACE gene
[88-89]. This polymorphic variation in ACE gene correlates with levels of both circulating
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[88] and tissue-localized ACE [90] and DD genotype is found to be associated with the high‐
est ACE levels.
Gene polymorphisms of the RAS, especially I/D polymorphism of ACE gene, were associat‐
ed with development of renal scarring in patients with congenital urological abnormalities
[91-95]. It was concluded that the DD genotype could be a genetic susceptibility factor con‐
tributing to renal parenchymal damage. In our previous study [96], we found a difference in
ACE I/D genotypes’ distribution in patients with bladder dysfunction according to pres‐
ence/absence of renal scarring. Although the two groups of patients (with and without scar‐
ring) did not differ by conventional risk factors, significant increase of D allele frequency
was present in patients with renal scarring [96]. Only few studies investigated effect of ACE
I/D polymorphism on renal scarring following APN. In Korean children frequencies of ACE
I/D genotypes and alleles were not different between renal scar-positive and scar-negative
groups, irrespectively of VUR [97]. Another study in Greek population did not confirm a
correlation between ACE DD genotype and renal scar formation in children with UTIs [98].
2.5.6. Meta-analysis of genetic susceptibility factors for renal scar formation following UTI
Recently, meta-analysis of candidate gene polymorphisms as genetic susceptibility factors
for renal scars’ formation following UTI has been performed [99]. After systematic analysis
of previously published data, the authors made strict inclusion criteria for this meta-analy‐
sis. From 523 original citations they identified only 18 articles that met the inclusion criteria.
The results of meta-analysis showed that, according to recessive model of inheritance, ACE
I/D polymorphism was a significant risk factor for renal scarring although with a high de‐
gree of between-study variability. According to dominant model, the T allele of TGF-β1 -509
C/T polymorphism was related to increased susceptibility for renal scarring, again with a
high degree of between-study variability [99].
The risk for renal scarring occurred in ACE DD genotype carriers [99]. This genotype was
correlated with increased expression of renal ACE [100] and thus with increased production
of Ang II. Ang II is a mediator of progressive renal failure [101] and it may induce expres‐
sion of TGF-β1, which is involved in pathogenesis of renal scarring [78,102]. There was no
correlation found between TGF-β1 -509 genotypes and TGF-β1 protein production [81].
Considering the results of current meta-analysis [99] and known effects of ACE I/D poly‐
morphism [100], it is of interest to study the effects of TGF-β1 -509 C/T gene polymorphism
on gene expression and TGF-β1 levels in renal tissue of UTI (APN) patients having renal
scars.
3. Conclusions
The symptoms of urinary tract infections (UTIs) depend on localization of infection and
magnitude of the host response to bacteria. There are many risk factors for UTIs such as gen‐
der, VUR, environmental and socio-economical factors and, as it is proposed and reviewed
here, genetic risk factors. Hence, UTIs represent a classical example of multifactorial disease
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combining gene-environment and probably gene-gene interactions. To date, association
with UTIs has been studied through a candidate gene approach. Among the candidate genes
are those that code for soluble mediators, receptors and adhesion molecules included in reg‐
ulation of the host response upon UTI. There are two basic approaches in these genetic stud‐
ies. The first approach, which is less common, involves investigation of the candidate genes’
effects on UTI susceptibility only (case-control study design). The second, more common ap‐
proach, is based on investigation of susceptibility to renal scarring as the most serious com‐
plication of UTI (case study design). The second approach has a greater clinical potential
since the primary aim of such research is to identify the patients susceptible to progressive
kidney damage, which often results in end-stage renal disease.
The field investigating genetic susceptibility to UTIs in humans started only a decade ago as
we can see from the reviewed articles. The first evidence that susceptibility to APN as well
as asymptomatic bacteriuria (ABU) could be inherited came only a few years ago [69,103].
As a consequence, limited number of studies has been performed. Most of these studies in‐
cluded children only, some of the rest included both children and adults, while others in‐
cluded adults only. This review is focused on studies in children. Besides the number of
studies, another limitation of research in this field is the number of participants included in
these studies. The majority of studies reviewed here had about 100 patients, only few had
up to 250. In further analysis of study design we must notice dividing of patients’ group in
subgroups- those with APN and those with lower UTI, and further dividing of the APN
subgroup according to presence/absence of renal scarring. These limitations must be mini‐
mized in order to improve the statistical power of studies. Nevertheless, the results so far
support the hypothesis of genetic impact on susceptibility to UTI/APN and give a good rea‐
son for further research.
Among genes mostly investigated in susceptibility to UTIs are the cytokine family genes.
Results suggest that IL-8 -251 A allele represents a risk factor for APN, after exclusion of pa‐
tients with VUR [18]. Single base changes in IL-8 receptor (CXCR1) gene, +217 C/G and
+2608 G/C, are associated with a risk for APN in both children and adults [56]. RANTES/
CCL5 -403 G allele is susceptibility factor for UTI, irrespectively of VUR [57].
The effects of TLRs genes’ polymorphisms are hard to summarize due to a large number of
genes and polymorphisms in this family and a small number of homogenous studies. It is
proposed that genetic variants in TLR4 promoter influence TLR4 expression as well as clini‐
cal presentation of UTI [69]. Probably the most intereting, recent findings are the results of
the group from Lundt University. Children with ABU express less TLR4 than APN prone
children or controls but do not carry structural gene mutations explaining this phenotype.
They recently defined the eight TLR4 promoter sequence variants, forming 19 haplotypes
and 29 genotype patterns. The ABU-associated genotypes reduced TLR4 expression and the
response to infection [56, 69]. Host susceptibility to common infections like UTI may thus be
strongly influenced by single gene modifications affecting the innate immune response. For
example, genetic alterations that reduce TLR4 function are associated with ABU, while poly‐
morphisms reducing IRF3 or CXCR1 expression are associated with acute pyelonephritis
and an increased risk for renal scarring [104]. The TLR1 +1805 G/T polymorphism is shown
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to protect against pyelonephritis in women [70]. It seems plausible to personalize the diag‐
nosis and therapy of APN and ABU in the future, by combining information on bacterial
virulence and the host response
To assess the genetic basis of renal scarring following UTI, many risk factors have to be ana‐
lyzed. As we discussed, the heterogeneity between studies is large. Therefore, we may only
point out to results of recent meta-analysis. The meta-analysis reveals that ACE I/D and
TGF-β1 -509 C/T polymorphisms are risk factors for development of renal scars following
UTI [99].
The most recent results strongly suggest the innate immunity as possible key factor for ge‐
netic susceptibility to APN and renal scarring after infection, although on murine models in
which certan genes are functionaly similar to humans. It was shown that acute pyelonephri‐
tis and renal scarring are caused by dysfunctional innate immunity in mCxcr2 heterozygous
mice [105].
Up to date no genome-wide association study has been done to use new approach for dis‐
covering novel genetic susceptibility factors for UTIs on a large number of individuals. New
approaches to risk assasment and therapy shoud be encouraged and it is time for UTI to
combine molecular medicine and social and behaviral factors. It is certain that some children
are protected from APN and others prone to severe and recurent infections. Also, some of
the gene polymorphisms are differentialy presented in those groups of children., The final
aim is to identify the patients genetically susceptible to renal scarring and to discover and
enable novel strategies in management of recurrent UTIs in order to prevent further renal
damage especially in susceptible children. Until then, the prophylactic antibiotic treatment
to prevent recurrent UTIs remains of limited usefulness [106].
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